Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 133 results for "Qualitest Pharmaceuticals"

Endo Completes Acquisition of Specialty Generics Company Boca ...

MALVERN, Penn. , Feb. 3, 2014 /PRNewswire/ -- Unique Generics Product Portfolio, Attractive Pipeline, Builds On Qualitest''s Strength In Controlled Substances Transaction Expected To Be Immediately Accretive To Endo''s Adjusted Diluted EPS Endo ... Asian Hospital & Healthcare Management, 1 month ago

Why Lone Pine bought a new position in Endo Health Solutions

Must-know update: Lone Pine Capital's positions in 4Q 2013 (Part 6 of 8) ( Continued from Part 5 ) Specialty pharmaceutical company Endo Health Solutions (ENDP) is a brand new 1.26% position initiated in the last quarter of 2013 by Lone Pine ...
 Yahoo! Finance1 month ago Millennium Management buys a position in Endo International  Yahoo! Finance3 weeks ago
4 Traders

Endo Pharmaceuticals To Announce Fourth Quarter 2013 Financial Results On February 28, 2014

MALVERN, Pa., Feb. 20, 2014 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) will announce its fourth quarter 2013 financial results before the open of the U.S. financial markets on February 28, 2014 and members of its senior management team ...
 BioSpace1 month ago Endo Health Solutions Reports net loss of $776M in fourth quarter 2013  News-Medical.Net1 month ago ENDO HEALTH SOLUTIONS INC. - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations  TMC Net1 month ago Endo Reports Fourth Quarter And Full Year 2013 Financial Results  Barchart1 month ago
[x]  

Endo International plc (ENDP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Summary: Endo reported higher-than-expected earnings but lower-than-expected revenues in the fourth quarter of 2013 primarily due to lower sales of Lidoderm and Opana ER. The company issued disappointing outlooks for 2014 both on revenues as well ...
 Zacks.com2 days ago Endo Health Solutions Receives Neutral Rating from Zacks (ENDP)  Mideast Time1 month ago Endo Health Solutions's Neutral Rating Reaffirmed at Zacks (ENDP)  American Banking News1 month ago

Q4 Earnings Decline Y/Y at Endo, Weak Outlook

Endo Health Solutions ( ENDP ) fourth quarter 2013 earnings (excluding special items) of 96 cents per share edged past the Zacks Consensus Estimate by 2 cents but decreased 41% from the year-ago period. Earnings in the final quarter of 2013 were ...
 Yahoo! Finance1 month ago Endo Health Solutions' CEO Discusses Q4 2013 Results - Earnings Call Transcript  Seeking Alpha1 month ago

Key drugs market sees steady gain in share: KRChoksey Shares and Securities

Indian companies performance in the US formulations space was remarkable in Q3FY14 According to KRChoksey Shares and Securities, Indian pharmaceutical companies performance in the US formulations space was remarkable in Q3FY14. The companies have ...
 Express Pharma1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less